| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |